The levels of SREBP-1 are significantly elevated in obese patients and animal models of obesity and type 2 diabetes; however, it appears that the contribution of SREBP-1 to improving insulin resistance is poor, because even in the absence of SREBP-1 elevated glucose levels persist. The gene discussed is SREBF1; the disease is obesity disorder.